# Oklahoma Blood Institute – FDA Inspection, Aug 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/c257f8b2-9f45-401b-ac2d-cbef054adbec
Source feed: FDA_Inspections

> FDA inspection 1284988 of Oklahoma Blood Institute, August 26, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1284988
- Company Name: Oklahoma Blood Institute
- Inspection Date: 2026-08-26
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1040193 - 2017-12-07
- [FDA Inspection 945909 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/225f3689-4f73-4eae-a4d2-e8e8e1918958)
- [FDA Inspection 830972 - 2013-05-08](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute/1e7d2fd2-a548-49d6-aa4c-306c4b609759)
- FDA Inspection 727157 - 2011-05-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christopher-j-adams/f7010846-7fd1-4ee8-901a-1015656fea0a)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute/fb4c6206-fc3f-4a34-a596-f57af9529062

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9